Survodutide hits where other weight loss drugs miss
Phase 3 data from the SYNCHRONIZE-1 trial shows the experimental drug reducing visceral and liver fat while preserving lean muscle mass in adults with obesity. Most weight loss medications work by suppressing appetite. Survodutide does that too, but the experimental drug developed by Boehringer Ingelheim is drawing attention for what it […]
New study finds 1 gene variant that boosts GLP-1 results
GLP-1 receptor agonists like semaglutide and tirzepatide have become some of the most talked about medications in modern medicine, reshaping how millions of people approach weight loss. But a sweeping new study suggests that the results people experience may have less to do with willpower or lifestyle and more to do with what is written […]
Mounjaro vs. Wegovy: What happens when you stop them
An estimated 1.6 million people in the United Kingdom are currently taking weight-loss drugs, and the numbers continue to grow. While some access these treatments through the National Health Service, the majority purchase them privately. The two most widely used options are Mounjaro and Wegovy injectable medications that have changed the conversation around obesity treatment. […]
Is retatrutide more effective than Ozempic for weight loss
Retatrutide still experimental and not yet approved by the U.S. Food and Drug Administration, the medication is already reshaping the way researchers think about weight loss medicine. Here is what experts currently know about it. Now, a newer drug is quietly generating some of the most significant buzz in clinical research. By now, most people […]
Wegovy Pill finally arrives and transforms weight loss
The FDA-approved oral GLP-1 pill is officially available across America, giving millions a powerful needle-free path to serious, lasting weight loss. Weight loss just got a whole lot easier to swallow — literally. The Wegovy pill, the first-ever oral GLP-1 medication approved for weight loss in the United States, is now available nationwide, and it […]